Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.
about
Kidney function is associated with an altered protein composition of high-density lipoprotein.PCSK9 in chronic kidney disease.Dyslipidaemia in nephrotic syndrome: mechanisms and treatment.Estrogen Receptor α Signaling Exacerbates Immune-Mediated Nephropathies through Alteration of Metabolic Activity.The role of lipoprotein (a) in chronic kidney disease.Dyslipidemia in people living with HIV-AIDS in a tertiary hospital in South-East Nigeria.Physiological Aldosterone Concentrations Are Associated with Alterations of Lipid Metabolism: Observations from the General Population.
P2860
Q38650168-133E4493-7D8A-4793-9157-6307E7893128Q39022581-197AACE0-B3C1-4061-A99F-3F5A2AEA89E5Q47363893-C3540E91-06F4-464F-A346-7B7E2FA57875Q47565445-6CADAF11-8014-41DE-BC0D-DE619CA7B35EQ49598174-DF81C9E6-059B-405E-864D-B24E6A84358FQ52722140-9FA29CCE-6CF3-4ECE-BC46-2B84A46EEB9AQ55310756-6D5369AC-E2E5-41AE-932B-BEED23986D70
P2860
Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.
@en
type
label
Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.
@en
prefLabel
Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.
@en
P2860
P1433
P1476
Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences.
@en
P2093
Nosratola D Vaziri
P2860
P356
10.1016/J.KINT.2016.02.026
P407
P577
2016-04-26T00:00:00Z